Authors:
SOLBERG R
SCHOLZ T
VIDEM V
OKKENHAUG C
AASEN AO
Citation: R. Solberg et al., HEPARIN COATING REDUCES CELL ACTIVATION AND MEDIATOR RELEASE IN AN IN-VITRO VENOVENOUS BYPASS MODEL FOR LIVER-TRANSPLANTATION, Transplant international, 11(4), 1998, pp. 252-258
Authors:
MOLLNES TE
FIANE AE
VIDEM V
SAHU A
HOVIG T
MELLBYE OJ
HOGASEN J
SPRUCE L
MOORE W
LAMBRIS JD
Citation: Te. Mollnes et al., ATTENUATION OF HYPERACUTE XENOGRAFT REJECTION IN A PORCINE-TO-HUMAN EX-VIVO MODEL BY A PEPTIDE-BASED C3 INHIBITOR, Molecular immunology, 35(6-7), 1998, pp. 167-167
Authors:
FIANE AE
VIDEM V
FOERSTER A
SCHOLZ T
PERDERSEN TH
KARLSEN H
SVENNEVIG JL
GEIRAN OR
AASEN AO
MOLLNES TE
Citation: Ae. Fiane et al., AN EX-VIVO PERFUSION MODEL TO EVALUATE HYPERACUTE REJECTION IN A DISCORDANT PIG-TO-HUMAN COMBINATION, European surgical research, 30(5), 1998, pp. 341-351
Authors:
BAKSAAS ST
VIDEM V
MOLLNES TE
PEDERSEN T
KARLSEN H
SVENNEVIG JL
Citation: St. Baksaas et al., EFFECTS ON COMPLEMENT, GRANULOCYTES AND PLATELETS OF A LEUKOCYTE-DEPLETION FILTER DURING IN-VITRO EXTRACORPOREAL-CIRCULATION, SC CARDIOVA, 31(2), 1997, pp. 73-77
Authors:
WILDEVUUR CRH
JANSEN PGM
BEZEMER PD
KUIK DJ
EIJSMAN L
BRUINS P
DEJONG AP
VANHARDEVELT FWJ
BIERVLIET JD
HASENKAM JM
KURE HH
KNUDSEN L
BELLAICHE L
AHLBURG P
LOISANCE DY
BAUFRETON C
LEBESNERAIS P
BAJAN G
MATTA A
VANDYCK M
RENOTTE MT
PONLOTLOIS A
BAELE P
MCGOVERN EA
MCCARTHY J
MCCARTHY A
ODONNELL A
FOSSE E
MOEN O
DREGELID E
BROCKMEIER V
ANDERSON C
POMAR JL
RANUCCI M
CONTI D
CIRRI S
CONTI E
DITTA A
VONSEGESSER LK
TKEBUCHAVA T
WEISS BM
TURINA MI
SVENNEVIG JL
MOHR B
VIDEM V
KARLSEN H
PEDERSEN TH
THELIN S
HALDEN E
HAGMAN L
THORNO E
AHLVIN E
Citation: Crh. Wildevuur et al., CLINICAL-EVALUATION OF DURAFLO(R)-II HEPARIN TREATED EXTRACORPOREAL-CIRCULATION CIRCUITS (2ND VERSION) - THE EUROPEAN WORKING GROUP ON HEPARIN COATED EXTRACORPOREAL-CIRCULATION CIRCUITS, European journal of cardio-thoracic surgery, 11(4), 1997, pp. 616-623
Authors:
FOSSE E
THELIN S
SVENNEVIG JL
JANSEN P
MOLLNES TE
HACK E
VENGE P
MOEN O
BROCKMEIER V
DREGELID E
HALDEN E
HAGMAN L
VIDEM V
PEDERSEN T
MOHR B
Citation: E. Fosse et al., DURAFLO-II COATING OF CARDIOPULMONARY BYPASS CIRCUITS REDUCES COMPLEMENT ACTIVATION, BUT DOES NOT AFFECT THE RELEASE OF GRANULOCYTE ENZYMESIN FULLY HEPARINIZED PATIENTS - A EUROPEAN MULTICENTER STUDY, European journal of cardio-thoracic surgery, 11(2), 1997, pp. 320-327
Authors:
PEDERSEN TH
VIDEM V
SVENNEVIG JL
KARLSEN H
OSTBAKK RW
JENSEN O
MOLLNES TE
Citation: Th. Pedersen et al., EXTRACORPOREAL MEMBRANE-OXYGENATION USING A CENTRIFUGAL PUMP AND A SERVO REGULATOR TO PREVENT NEGATIVE INLET PRESSURE, The Annals of thoracic surgery, 63(5), 1997, pp. 1333-1339
Citation: E. Ovrum et V. Videm, ANTITHROMBIN-III, LEUKOCYTE ACTIVATION, AND LOW SYSTEMIC HEPARINIZATION - REPLY, The Annals of thoracic surgery, 63(4), 1997, pp. 1211-1212
Citation: V. Videm, HEPARIN IN CLINICAL DOSES PRIMES GRANULOCYTES TO SUBSEQUENT ACTIVATION AS MEASURED BY MYELOPEROXIDASE RELEASE, Scandinavian journal of immunology, 43(4), 1996, pp. 385-390
Authors:
KUROKI K
ROY S
LAERUM F
MOLLNES TE
SOLHEIM BG
VIDEM V
Citation: K. Kuroki et al., COMPLEMENT ACTIVATION BY ANGIOGRAPHIC CATHETERS IN-VITRO, Journal of vascular and interventional radiology, 6(5), 1995, pp. 819-826
Authors:
OVRUM E
MOLLNES TE
FOSSE E
HOLEN EA
TANGEN G
RINGDAL MAL
VIDEM V
Citation: E. Ovrum et al., HIGH AND LOW HEPARIN DOSE WITH HEPARIN-COATED CARDIOPULMONARY BYPASS - ACTIVATION OF COMPLEMENT AND GRANULOCYTES, The Annals of thoracic surgery, 60(6), 1995, pp. 1755-1761
Citation: V. Videm et Te. Mollnes, HUMAN-COMPLEMENT ACTIVATION BY POLYGELINE AND DEXTRAN-70, Scandinavian journal of immunology, 39(3), 1994, pp. 314-320
Citation: V. Videm, HEPARIN-COATED CARDIOPULMONARY BYPASS CIRCUITS - HEMOSTATIC ALTERATIONS AND POSTOPERATIVE BLOOD-LOSS - COMMENTARY, The Annals of thoracic surgery, 58(3), 1994, pp. 741-741